- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01703676
Epigenetics and Metabolic Disorders in Men With the Klinefelter Syndrome (IZKF-CRA03-09)
October 12, 2012 updated by: Zitzmann, University Hospital Muenster
Klinefelter Syndrome: Do the Parental Origin and Epigenetic Profile of the Supernumerary X Chromosome Determine Phenotype, Morbidity, Inflammatory Status and Cardiovascular Risk?
This study will elucidate how the parental origin of the X-chromosome influences health status as well as metabolic fate in Klinefelter patients.
Epigenetics and transcriptome-research will be directly linked to the metabolic and inflammatory pattern of actual patients to improve care for them.
The Klinefelter Syndrome is one of the most common genetic disorders in men.
The patients have one supernumerary X-chromosome, which is partly active and disturbs a normal male development.
Testosterone deficiency in form of primary hypogonadism is a common feature in these men.
Such a condition promotes clinically relevant metabolic patterns related to a pro-inflammatory status and diabetes mellitus type 2 (insulin resis-tance), cardiovascular disease as well as infertility.
However, the variety of pathologies is pro-nounced between patients and low testosterone concentrations cannot fully explain the wide scope of pathologies in these men.
Some patients become clinically obvious during puberty and adoles-cence, some in their thirties or later and all exhibit a huge variation in phenotype.
Switching on and off of specific genes on the X-chromosome is differential, depending on the origin either from the maternal or paternal side.
Hence, an influence on the clinical picture is hypothesised.
Thus, key targets are clarification of the parental origin of the supernumerary X chromosome and elucidation of methylation and expression profile of pivotal X-chromosomal genes.
These will be related to clinically relevant metabolic and inflammatory patterns as well as fertility to identify individual risks as well as treatment strategies for Klinefelter patients.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
300
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients, their parents, male controls, female controls
Description
Inclusion Criteria:
Klinefelter Syndrome
Exclusion Criteria:
Mosaic status
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients
Klinefelter Patients
|
Parents
Parents of Klinefelter Patients
|
Controls M
Healthy Male Control with normal karyotype
|
Controls F
Healthy female controls
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Zitzmann, MD, PhD, University Hospital Muenster
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
October 5, 2012
First Submitted That Met QC Criteria
October 5, 2012
First Posted (Estimate)
October 10, 2012
Study Record Updates
Last Update Posted (Estimate)
October 15, 2012
Last Update Submitted That Met QC Criteria
October 12, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Endocrine System Diseases
- Disease
- Gonadal Disorders
- Disorders of Sex Development
- Urogenital Abnormalities
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Chromosome Disorders
- Sex Chromosome Disorders
- Sex Chromosome Disorders of Sex Development
- Syndrome
- Hypogonadism
- Klinefelter Syndrome
Other Study ID Numbers
- EpigenMetabDisordKlinefelter
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Klinefelter Syndrome, Hypogonadism
-
University of Roma La SapienzaCompletedKlinefelter Syndrome | Hypergonadotropic Hypogonadism | Hypergonadotropic Azospermia | Hypergonadotropic CryptozoospermiaItaly
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingKlinefelter SyndromeUnited States
-
Thomas Jefferson UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
University of Colorado, DenverCompletedKlinefelter SyndromeUnited States
-
Hospices Civils de LyonCompletedKlinefelter SyndromeFrance
-
University of PittsburghTerminated
-
Odense University HospitalAarhus University Hospital; University of CopenhagenCompleted
-
University of Colorado, DenverNational Institute of Neurological Disorders and Stroke (NINDS); Children's... and other collaboratorsCompletedKlinefelter Syndrome | XXY SyndromeUnited States
-
National Human Genome Research Institute (NHGRI)CompletedKlinefelter SyndromeUnited States